SYCP3 and cervical carcinoma: Of the 400 CIN specimens, 344 (86.0%) were available to confirm co-expression between SCP3 and pAKT, whereas 173 tumor samples (95.6%) were available to confirm co-expression between SCP3 and pAKT in cervical cancer.